Loading...
Moleculin Biotech, Inc.
MBRX•NASDAQ
Healthcare
Biotechnology
$0.32
$0.03(9.30%)
Moleculin Biotech, Inc. (MBRX) Financial Performance & Statements
Review Moleculin Biotech, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
10.09%
↑ 10.09%
Net Income Growth
26.89%
↑ 26.89%
Operating Cash Flow Growth
0.99%
↑ 0.99%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-297.76%
↓ 297.76%
ROIC
-183.51%
↓ 183.51%
Moleculin Biotech, Inc. (MBRX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Moleculin Biotech, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $63000.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $31000.00 | $32000.00 |
| Gross Profit | $63000.00 | $0.00 | -$31000.00 | -$32000.00 |
| Gross Profit Ratio | $1.00 | $0.00 | ||
| R&D Expenses | $4.46M | $4.93M | $4.09M | $4.25M |
| SG&A Expenses | $2.16M | $2.17M | $2.06M | $2.39M |
| Operating Expenses | $6.61M | $7.13M | $6.15M | $6.64M |
| Total Costs & Expenses | $6.67M | $7.13M | $6.18M | $6.68M |
| Interest Income | $47000.00 | $102000.00 | $159000.00 | $241000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $31000.00 | $31000.00 | $31000.00 | $32000.00 |
| EBITDA | -$6.61M | -$7.10M | -$6.15M | -$6.64M |
| EBITDA Ratio | -$104.95 | |||
| Operating Income | -$6.64M | -$7.13M | -$6.18M | -$6.68M |
| Operating Income Ratio | -$105.44 | |||
| Other Income/Expenses (Net) | $4.76M | -$3.46M | $1.87M | $1.71M |
| Income Before Tax | -$1.88M | -$10.59M | -$4.32M | -$4.97M |
| Income Before Tax Ratio | -$29.87 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$11276.00 |
| Net Income | -$1.88M | -$10.59M | -$4.32M | -$4.97M |
| Net Income Ratio | -$29.87 | |||
| EPS | -$0.55 | -$2.85 | -$1.70 | -$2.02 |
| Diluted EPS | -$0.55 | -$2.85 | -$1.70 | -$2.02 |
| Weighted Avg Shares Outstanding | $3.38M | $3.71M | $2.54M | $2.47M |
| Weighted Avg Shares Outstanding (Diluted) | $3.38M | $3.71M | $2.54M | $2.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan